Exploring novel therapies for preeclampsia: the role of soluble prorenin receptor on vasculature function

Project: Research

StatusFinished
Effective start/end date7/11/177/11/18

Funding

  • Ferring Pharmaceuticals Pty Ltd: AUD147,350.00